I am back from my vacation, some updates and notes:
Saleorder I installed for BT Group striked and I sold my Position with an acceptable profit (annualized). I am still not sure if I want to do things like that in the future considering the risk/reward profile of that
Foot Looker released some good Q4 numbers. The stock now sales for ~15.5 earnings. Btw. I like their reporting.
The Company’s net income increased to $664 million in 2016, or $ 4.91 per share, compared to net income of $541million, or $3.84 per share in 2015.
Seems like Hormel Foods
and L Brands disappointed investors. Both stocks lost recently. I am planing to lock at them.
French Vivendi goes down and down slowly… maybe I will look at it again. (Bollore stayed more or less flat)
To Do list:
- Read Warren Buffett’s Annual Letter
- looking at Hormel Foods again
- looking at Danaher
- looking at Vivendi
- looking at L Brands (Victorias Secret)
A great List of Q4 Letters and Reports at reddit (link)
Including: RV Capital, Fairholme, Third Point, Tweedy Browne, Sequoia, Bill Gross, … and many more!
(also see my quality-sources section for more stuff like that)
If you are searching for Baupost/Seth Klarman try this link
The Brooklyn Investor, always worth a read: Bogle Book, Indexing etc.
So Why Not Buy Apple.?! form Wexboy
Are UK Equities overvalued from at woodfordfunds
The UK stock market’s current PE of about 15x this year’s anticipated earnings, implies a real annualised total return of approximately 8% over the next 10 years, based on the historic trend shown on the chart. This isn’t bad, in our view, especially when compared to the likely returns available from other asset classes.
If you always wanted to see how Warren Buffett orders sausage mc muffin at McDrive on the way to work – today is your day!
If link is broken try this search
MMI from valueandopportunity came up with this two special situations which leed to this actions:
Bought 2,3% Position of Actelion on Friday
Bought 2,5,% Position of Sapec SA Today
Disclaimer: This is not investment advice. The stock mentioned is relatively illiquid and potentially risky. Please do your own research !!!!
Seems like the deal is finished (link)
I think the Newco is also on a standalone basis very interesting because 1.) the current CEO stays with them, and 2.) the imbalance between the Actelion (280$) and Newco (~10$) price could create a lot of “forced” sales on the first days of trading.
Since it lost ~20% on one Trading day and has a “brand” name I have looked at UA but for me it was still very expensive and the move in fashion sounds very risky for me – no buy from me here.
Disclosure: Long Sapec & Actelion
The content contained on this site represents only the opinions of its author(s). I may hold a position in securities mentioned on this site. In no way should anything on this website be considered investment advice and should never be relied on in making an investment decision. As always please do your own research!
KraftHeinz and 3G (link)
Unlike other PE firms, which have an exit in mind from the day they buy a company, Lemann and partners have stuck with their beer venture for 28 years and counting.
Bloomberg: Buffett Bought $12 Billion of Stock From Election Through Friday (link)
Morningstar: Top 10 Investment Trust in November Link
“The healthcare opportunity” from at Woodford. (link) Woodford is one of my Quality Sources
As our regular readers will have gathered, we have strong conviction in the long-term investment case for the healthcare industry.
Note2: The interactive infographics are fun
Whitbread which I mentioned here recently came up with some good numbers (link)
Britvic had a Strong start to the year and is confident of meeting market expectations (link)
GB carbonates continued its outperformance of the market with a revenue increase of 5.5%.
France revenue increased 6.3% with the branded portfolio in strong growth
Ireland revenue increased 6.4%, with both Counterpoint and our branded business performing well.
The International division reported a 19.8% increase in revenue, compared to a 13.8% decline in Q1 last year and was largely as a result of a 14.1% increase in volume.
Paypal reports 21% FX-Neutral YoY revenue Growth and expects 14-16% revenue increase in 2017 (link)
Walgreens reduced its offer for RiteAid “based on the number of required store divestitures” (link)
will be a maximum of $7.00 per share and a minimum of $6.50 per share
Note: the RiteAid stock is now at 5,62 USD